Potential two‐step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study

Abstract Introduction We sought to determine if our previously validated proteomic profile for detecting Alzheimer's disease would detect Parkinson's disease (PD) and distinguish PD from other neurodegenerative diseases. Methods Plasma samples were assayed from 150 patients of the Harvard...

Full description

Bibliographic Details
Main Authors: Sid E. O'Bryant, Melissa Edwards, Fan Zhang, Leigh A. Johnson, James Hall, Yuliya Kuras, Clemens R. Scherzer
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1016/j.dadm.2019.03.001